Cost & Price Transparency
Expert articles and analysis related to cost & price transparency.
AI Summary — Last 24 Hours
In the past 24 hours, CMS finalized 2027 policy and rate changes for Medicare Advantage and Part D, signaling potentially significant impacts on value-based care contracts and payment structures for Medicare stakeholders (AHCA/NCAL coverage). Meanwhile, large payers such as Optum and P3 Health Partners are reporting sharp reductions in nursing home admissions and highlighting the heightened relevance of their value-based care models, pointing to immediate cost containment and care transformation implications ([Skilled
Related Articles
The $500,000 drug and the cost of modern medicine
I met him as a patient with a back condition, not a cardiac patient. A 70-year-old man who looked like he had outrun aging through sheer willpower and a well-worn bicycle. He rode more than a hundred ...
Blue Shield of California taps chief pharmacy officer
Hayley Park will oversee BSCA’s prescription drug programs. The insurer has worked to overhaul its pharmacy management model in a bid to lower drug costs.
Rep. Blake Moore discusses health care affordability
Rep. Blake Moore discusses health care affordability American Hospital Association
Pharmacy system saves Texas Children's Hospital $14M, and that's just for starters
The pharmacy at Texas Children's Hospital faced a fundamental lack of accurate, real-time inventory visibility across the enterprise. Leaders and clinicians had no reliable way to answer a simple ques...
PBM proposed transparency rule supported by public comment
The public comment period is now closed for a Department of Labor proposed rule for improving transparency in pharmacy benefit manager fees.The Department of Labor opened comment on Jan. 30 and closed...
More than 70% of CFOs report margins of 2% or less
In a survey of CFOs and financial leaders, 72% are reporting margins of 2% or lower, a razor-thin profit percentage more typical of high-volume grocery stores.The financial challenges are led by reimb...
Providers push back on 340B rebate model
Hospitals and clinics told regulators that switching to rebates in the 340B drug discount program would impose costs that would outweigh the program’s benefits.
Some States Blunted the Impact of Lost Federal Marketplace Subsidies, But Efforts Will Be Hard to Sustain
Some States Blunted the Impact of Lost Federal Marketplace Subsidies, But Efforts Will Be Hard to Sustain Commonwealth Fund
Employers flex healthcare muscles on Capitol Hill as costs spike
Employers flex healthcare muscles on Capitol Hill as costs spike Modern Healthcare
Listen: Cheap Health Insurance Isn’t Always Cheap
Across the country, people are choosing lower monthly premiums in exchange for higher out-of-pocket risk. Reporter Jackie Fortiér explains what the shift means for Americans’ health and wallets.